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. Changes in thyroid function tests in FDH
• measured by analogue assay • measured by equilibrium dialysis or ultrafiltration fluctuations in albumin concentrations have little influence on the total concentration of the thyroid hormones in serum. Besides, in FDH these are usually normal. Under normal circumstances the affinity of albumin for thyroid hormone is low, due to the fact that albumin contains five or six specific binding sites for thyroxine, though only one of these seems to be a major thyroxine-binding site 14 • However, the binding capacity of albumin for thyroid hormone is very large due to the abundance of the protein.
Therefore the increased thyroxine-binding capacity must be caused by the occupation of more than one, or perhaps all of the binding sites, or possibly there are modified albumins containing more binding sites than normal. The suggestion by Lalloz and coworkers" that the albumin molecule exists in varying modifications with different binding properties is supported by the findings of Yabu and his group'", i.e, the abnormal T 4·binding in FDH is caused by an over-abundance of albumins with high affinities for thyroxine. These albumins are also present in normal serum, but only in minute concentrations'", However, it is still uncertain whether the modifications in albumins affect the existing binding sites, or if new binding sites are present.
In FDH the serum albumin has a normal affinity to T s and reverse T s (rT s ), resulting in normal levels ofT s and rT s . Recently two other albumins exhibiting differential binding to the iodothyronines have been defined. The one produces increased T 4 and rT s (Type II), while the other results in raised T 4 , T s and rT s (Type III). The 
Increased
Incidence FDH is an autosomal dominant inherited condition caused by enhanced binding of thyroxine by abnormal albumin, leading to increased T 4 • The condition was first described in 1979 by Henneman-and Lee" and their colleagues, and approximately 90 members of some 30 families have since been reported as possessing the abnormal albumin 4 -1S • Though now recognized with increasing frequency, the incidence is unknown, since most cases are found by chance. A reasonable estimate of the prevalence is 1 : 10 000, a figure indicated from screening of blood donors (unpublished observation).
It has become increasingly clear during the past few years that hyperthyroxinaemia can present in different ways without signs of accompanying hypermetabolism. The term 'euthyroid hyperthyroxinaemia' encompasses abroad range of disorders and conditions that can easily be misinterpreted as hyperthyroidism, and diagnostic difficulties can result. The most common aetiologies of euthyroid hyperthyroxinaemia are quantitative or qualitative changes in serum binding proteins, including circulating autoantibodies against thyroid hormones, and resistance to thyroid hormones. The condition can also occur temporarily, associated with severe non-thyroid diseases, and following ingestion of certain hormones and drugs1.
In this review the features of one euthyroid hyper. thyroxinaemia state -familial dysalbuminaemic hyper. thyroxinaemia (FDH)-are described and the diagnostic problems emphasized.
Pathophysiology
More than 99.9% of the thyroid hormones circulate in the blood closely bound to plasma proteins. Approximately 0.02% of the serum total thyroxine (T 4 ) and 0.3% of the serum total triiodothyronine (T s) are not bound to plasma proteins. Most important among these are thyroxine-binding globulin (TBG),thyroxine. binding prealbumin (TBPA) and albumin. Seventy. five percent of T 4 is usually bound by TBG, 15% by TBPA and 10% by albumin. The T s is distributed differently. with approximately 38% on TBG, 27% on TBPA and 35% on albumin.
An increase in the binding capacity or affinity of these binding proteins can raise the level of both T 4 and, to a lesser degree, T3' However, as the unbound (free) hormone concentrations remain unchanged, the metabolic activity is normal, i.e, the individual is euthyroid. In FDH the albumin molecules carry more thyroxine than normal. As only 10% of the T 4 is bound to albumin, it is evident that even extreme and with peripheral resistance to thyroid hormones as well.
In all the variants mentioned above, serum free thyroxine (free T 4) is normal when measured by ultrafiltration and equilibrium dialysis techniques, but spuriously raised by analogue methods (see below).
Thyroid function tests FDH causes a number of alterations in thyroid function tests that mimic hyperthyroidism ( Table 1) . Free T 4 may be falsely raised due to methodological artefacts, and therefore this parameter proves to be an important diagnostic pitfall (see below). Furthermore, T a and the binding of'T; to the albumin variant are normal (in Type D, and an uptake test using radiolabelled T a (RTaU) does not reflect the presence of a T 4-binding abnormality. Hence, the free thyroxine index (FT4I), which is the mathematical product of T a and RTaU, will be spuriously raised. The affected individuals may thus erroneously be suspected of having thyrotoxicosis, and in fact many of the cases reported have received antithyroid treatment4.9.12.19 or even strumectomy4.
A cardinal point in establishing the correct diagnosis of FDH is a correct measurement of free T 4, and, as mentioned, ultrafiltration methods and equilibrium dialysis techniques give euthyroid values in FDH. Discrepancies in free T 4 measurements arise with the use of one of the many commercially available assays based on a labelled thyroxine analogue in the radioimmunoassay method. This technique includes a 125I-thyroxine derivative which competes with free thyroxine for antibody-binding sites. According to the manufacturers the tracer does not bind to the major binding proteins in normal serum, but in clinical practice the analogue binds avidly to albumin and thus also in abundance to the variant albumin in FDH, with an increase in affinity estimated at about 20_30%15. These methods, therefore, yield artefactually high values of free T 4 in FDH20.21.
Diagnosis
Euthyroid hyperthyroxinaemia should be suspected when T a, rT a and valid estimates of free T 4 are normal, in spite of a raised T 4. The subject is euthyroid and usually without goitre and exophthalmos. However, when consulting the physician the patient may be concerned about his or her condition and a slight thyrotoxic appearance might ensue, i.e. nervousness, tachycardia, sweatingand perhaps tremor ofthe hands.
In cases of doubt, further thyroid function tests are required, of which the most important are the thyrotropin-releasing hormone (TRH) test and the basal thyroid-stimulating hormone (TSH) in serum (see below). A 24-hour 1a1I-uptake test is within the normal range, and the serum concentrations of the binding proteins are normal. A definitive diagnosis of FDH can only be made by finding abnormally high radioactivity in the albumin band on electrophoresis of the test serum trace labelled with 125I-thyroxine.
Traditional radioimmunoassays for TSH have been unable to discriminate between the normal levels of TSH in euthyroid individuals and the reduced levels in hyperthyroidism, due to lack of sensitivity. Basal TSH estimations have therefore not been useful in distinguishing between FDH (or other euthyroid hyperthyroxinaemic states) and true thyroid Journal of the Royal Society of Medicine Volume 81 January 1988 35 disease. Recently, however, assays based on immuneradiometric methods using monoclonal antibodies against TSH have proved to be much more sensitive, making it possible to detect the clearly reduced values of serum TSH in hyperthyroidism as opposed to the normal values in euthyroidism.
Differential diagnosis
Other causes of euthyroid hyperthyroxinaemia can be subdivided into four categories:
Binding protein changes
An increased serum TBG concentration is the commonest cause of concurrent elevations of the serum T 4 (and T a) concentrations. Hyperoestrogenaemia increases the synthesis of TBG, for instance when oestrogen is administered exogenously (e.g. use of oral contraceptives with high oestrogen content), and with higher endogenous release (e.g. during pregnancy). Diseases of the liver, notably acute hepatitis, chronic active hepatitis and biliary cirrhosis, and acute intermittent porphyria and certain oestrogen-producing tumours may also be associated with increased concentrations of TBG1. Ultimately, TBG excess may present as a familial disorder, usually transmitted as an X-linked trait. Drug-induced hyper-TBG will be mentioned below.
The most unusual form of euthyroid hyperthyroxinaemia due to abnormal binding to carrier proteins is increased thyroxine binding to TBPA, only 6 cases having been reported12.22.2a. Interestingly, a patient with coexistent abnormal albumin and abnormal prealbumin has recently been reported'", Circulating autoantibodies against thyroxine, causing hyperthyroxinaemia, have been found in patients with Hashimoto's thyroiditis and with papillary carcinoma. Apart from contributing with additional binding sites, such antibodies may interfere with the measurements of T 4 by radioimmunoassay techniques, by binding the labelled thyroxine. They are detected by electrophoresis of serum labelled with 125I·thyroxine 25 • A significant proportion of the tracer will be detected in the immunoglobulin zone.
Resistance to thyroid hormones
Since the first report of this syndrome 26 in 1967, an increasing number ofcases have been reported. Tissue sensitivity to thyroid hormones is reduced to varying degrees in different tissues. In some the resistance is confined to the pituitary, leading to excessive TSH secretion and thyrotoxicosis, while in others the pituitary is spared (peripheral resistance). However, the most commonly recognized form of the syndrome is a combined pituitary (central) and peripheral defect, i.e. a generalized resistance, leading to elevated concentrations of the thyroid hormones (total and free) and to normal or increased TSH, and increased response ofTSH to TRH27. The mechanisms responsible for the resistance to thyroid hormones are incompletely understood.
Non-thyroidal illness
In patients with severe acute somatic or psychiatric illnesses of all categories, thyroid function tests are often abnormal without clinical evidence of thyroid dysfunction. Although the changes usually consist of low values of T a with normal T 4 values, isolated hyperthyroxinaemia is occasionally found28.29. Some of these patients have underlying hyperthyroidism FOH  I  N  N  I  N  N  N  N  N  TBG, increased  I  I  R  N  N  N  I  N  N  TBPA, increased affinity  I  N  N  I  N  N  N  N  N  Anti-T, autoantibodies  I  N  N  I  N  N  N  N  N  Thyroid hormone resistance  I  I  N·I  I  I  I  N-I  N Conditions and illnesses with an increase in TBG and subsequent hyperthyroxinaemia have been mentioned previously.
Drugs
Various drugs can lead to hyperthyroxinaemia by differing mechanisms. Inhibition of T, to T s conversion, reflected in a low T s and high rT s and T 4 , is caused by certain cholecystographic dyes and possibly by high-dose propranolol'. Amiodarone may act as an inhibitor of T 4 to T s conversion, but is also apt to induce hyperthyroidism, possibly as a result of a high iodine content.
An oestrogen-like effect on serum concentrations of TBG has occasionally been associated with the use of heroin, methadone, perphenazine, clofibrate, fluoracil and tamoxifen. Amphetamines can induce hyperthyroxinaemia, possibly as a result of a central effect, i.e, at hypothalamic or pituitary level. Elevations of serum thyroxine are ultimately found in clinically euthyroid patients who are receiving exogenous thyroxine administration.
As stated above, there are several causes of euthyroid hyperthyroxinaemia, and it is important to identify them to avoid a false diagnosis of T 4·toxicosis. Their most important distinguishing characteristics are shown in Table 2 .
Discussion
Subjects with FDH are euthyroid and the raised T 4 is usually found in a screening test. The importance of the syndrome is that these patients are generally mistakenly thought to be thyrotoxic; many of the reported cases have received treatment with thionamides and some have even received definitive treatment -obviously unnecessary and potentially harmful.
How then can a mistaken diagnosis be avoided? In the absence of overt hyperthyroidism, the patient and the laboratory tests should be carefully re-evaluated, including drug exposure and family history. In doubtful cases, further investigations are mandatory; a normal TRH·stimulation test excludes hyperthyroidism. Furthermore, the clinical euthyroid state can be assumed when Tsand free T 4 measured by a reliable method are normal. With respect to the TRHtest, an absent TSH response does not exclude euthyroidism. A lack of increase in TSH is found in hyperthyroidism (except in extremely rare cases of pituitary thyrotoxicosis), but unfortunately also in some other conditions, e.g. during remissions of Graves' disease, in patients with autonomous nodules (solitary or multiple) and in hypopituitarism'P. Drugs may also influence the TSH responses'. However, it is important to bear in mind that persons with almost any kind of euthyroid hyperthyroxinaemia generally feel well and have no specific symptoms.
Another approach uses basal TSH measured with a high-sensitive assay as a first line test, which immediately confirms the euthyroid state and renders other tests superfluous.
In FDH the RT 3 U is normal and the FT 4I increased, usually indications of hyperthyroidism. While a conventional RT 3 U uses radiolabelled triiodothyronine, a test using radiolabelled thyroxine, i.e. a T 4·uptake test (RT 4 U ), may distinguish patients with FDH from those with hyperthyroidism. This test has been used by White et at. 32 and has been shown to be of diagnostic value in FDH12.
When FDH has been definitely diagnosed, screening of the patient's immediate family should be carried out. IT impossible or inconvenient, the family and their physicians should be informed of the syndrome and its presence in the family, to avoid fruitless diagnostic studies and unnecessary treatment in the other members of the family.
In conclusion, recognition of FDH as well as other causes of euthyroid hyperthyroxinaemia is important to prevent inappropriate therapy. Isolated excess of T 4 , and even raised FT 41 when associated with a normal T 3 and rT 3 , should always lead to extensive investigations of thyroid function, the pituitarythyroid axis, free T 4 measured by reliable assays, and occasionally tests for abnormal hormone-binding.
